 | • レポートコード：QYR2104Z5295 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、小細胞肺がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・小細胞肺がん治療薬の市場動向 ・企業の競争状況、市場シェア ・小細胞肺がん治療薬の種類別市場規模（生物製剤、小分子） ・小細胞肺がん治療薬の用途別市場規模（病院、診療所、その他） ・小細胞肺がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・小細胞肺がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・小細胞肺がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・小細胞肺がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・小細胞肺がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Bristol-Myers Squibb、GlaxoSmithKline、Menarini、Ziopharm Oncology、Merck、Novartis、AstraZeneca、Takeda Pharmaceutical、Teva Pharmaceutical、Eli Lilly、Mylan、Sun Pharmaceuticals Industries、Amgen、Ono Pharmaceutical、Shanghai Jinhe Bio-Technology） ・結論 |
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market.
Market Analysis and Insights: Global Small Cell Lung Cancer Therapeutics Market
The global Small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Small Cell Lung Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Small Cell Lung Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Small Cell Lung Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Small Cell Lung Cancer Therapeutics market.
Global Small Cell Lung Cancer Therapeutics Scope and Market Size
Small Cell Lung Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Cell Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Biologics
Small molecules
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Ziopharm Oncology
Merck
Novartis
AstraZeneca
Takeda Pharmaceutical
Menarini
Ziopharm Oncology
Mylan
Sun Pharmaceuticals Industries
Amgen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics
1.2.3 Small molecules
1.3 Market by Application
1.3.1 Global Small Cell Lung Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Small Cell Lung Cancer Therapeutics Market Perspective (2016-2027)
2.2 Small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Small Cell Lung Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Small Cell Lung Cancer Therapeutics Industry Dynamic
2.3.1 Small Cell Lung Cancer Therapeutics Market Trends
2.3.2 Small Cell Lung Cancer Therapeutics Market Drivers
2.3.3 Small Cell Lung Cancer Therapeutics Market Challenges
2.3.4 Small Cell Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Cell Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Small Cell Lung Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Small Cell Lung Cancer Therapeutics Revenue
3.4 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Cell Lung Cancer Therapeutics Revenue in 2020
3.5 Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Small Cell Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Small Cell Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Cell Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Small Cell Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Small Cell Lung Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
6.2 North America Small Cell Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Small Cell Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Small Cell Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Small Cell Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Small Cell Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Small Cell Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Small Cell Lung Cancer Therapeutics Introduction
11.1.4 Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Small Cell Lung Cancer Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Menarini
11.4.1 Menarini Company Details
11.4.2 Menarini Business Overview
11.4.3 Menarini Small Cell Lung Cancer Therapeutics Introduction
11.4.4 Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.4.5 Menarini Recent Development
11.5 Ziopharm Oncology
11.5.1 Ziopharm Oncology Company Details
11.5.2 Ziopharm Oncology Business Overview
11.5.3 Ziopharm Oncology Small Cell Lung Cancer Therapeutics Introduction
11.5.4 Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.5.5 Ziopharm Oncology Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Small Cell Lung Cancer Therapeutics Introduction
11.6.4 Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Small Cell Lung Cancer Therapeutics Introduction
11.7.4 Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Small Cell Lung Cancer Therapeutics Introduction
11.8.4 AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
11.9.4 Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Details
11.10.2 Teva Pharmaceutical Business Overview
11.10.3 Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
11.10.4 Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.10.5 Teva Pharmaceutical Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Small Cell Lung Cancer Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Small Cell Lung Cancer Therapeutics Introduction
11.12.4 Mylan Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.12.5 Mylan Recent Development
11.13 Sun Pharmaceuticals Industries
11.13.1 Sun Pharmaceuticals Industries Company Details
11.13.2 Sun Pharmaceuticals Industries Business Overview
11.13.3 Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Introduction
11.13.4 Sun Pharmaceuticals Industries Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.13.5 Sun Pharmaceuticals Industries Recent Development
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Small Cell Lung Cancer Therapeutics Introduction
11.14.4 Amgen Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.14.5 Amgen Recent Development
11.15 Ono Pharmaceutical
11.15.1 Ono Pharmaceutical Company Details
11.15.2 Ono Pharmaceutical Business Overview
11.15.3 Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
11.15.4 Ono Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.15.5 Ono Pharmaceutical Recent Development
11.16 Shanghai Jinhe Bio-Technology
11.16.1 Shanghai Jinhe Bio-Technology Company Details
11.16.2 Shanghai Jinhe Bio-Technology Business Overview
11.16.3 Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Introduction
11.16.4 Shanghai Jinhe Bio-Technology Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.16.5 Shanghai Jinhe Bio-Technology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics
Table 3. Key Players of Small molecules
Table 4. Global Small Cell Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Small Cell Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Small Cell Lung Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Small Cell Lung Cancer Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Table 10. Small Cell Lung Cancer Therapeutics Market Trends
Table 11. Small Cell Lung Cancer Therapeutics Market Drivers
Table 12. Small Cell Lung Cancer Therapeutics Market Challenges
Table 13. Small Cell Lung Cancer Therapeutics Market Restraints
Table 14. Global Small Cell Lung Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Small Cell Lung Cancer Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2020)
Table 17. Ranking of Global Top Small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Small Cell Lung Cancer Therapeutics Product Solution and Service
Table 21. Date of Enter into Small Cell Lung Cancer Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Small Cell Lung Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Small Cell Lung Cancer Therapeutics Product
Table 64. Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Product
Table 69. Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Small Cell Lung Cancer Therapeutics Product
Table 74. GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Menarini Company Details
Table 77. Menarini Business Overview
Table 78. Menarini Small Cell Lung Cancer Therapeutics Product
Table 79. Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Menarini Recent Development
Table 81. Ziopharm Oncology Company Details
Table 82. Ziopharm Oncology Business Overview
Table 83. Ziopharm Oncology Small Cell Lung Cancer Therapeutics Product
Table 84. Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Ziopharm Oncology Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Small Cell Lung Cancer Therapeutics Product
Table 89. Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Small Cell Lung Cancer Therapeutics Product
Table 94. Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Takeda Pharmaceutical Company Details
Table 101. Takeda Pharmaceutical Business Overview
Table 102. Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Product
Table 103. Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Takeda Pharmaceutical Recent Development
Table 105. Teva Pharmaceutical Company Details
Table 106. Teva Pharmaceutical Business Overview
Table 107. Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Product
Table 108. Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Teva Pharmaceutical Recent Development
Table 110. Eli Lilly Company Details
Table 111. Eli Lilly Business Overview
Table 112. Eli Lilly Small Cell Lung Cancer Therapeutics Product
Table 113. Eli Lilly Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Eli Lilly Recent Development
Table 115. Mylan Company Details
Table 116. Mylan Business Overview
Table 117. Mylan Small Cell Lung Cancer Therapeutics Product
Table 118. Mylan Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Mylan Recent Development
Table 120. Sun Pharmaceuticals Industries Company Details
Table 121. Sun Pharmaceuticals Industries Business Overview
Table 122. Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Product
Table 123. Sun Pharmaceuticals Industries Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Sun Pharmaceuticals Industries Recent Development
Table 125. Amgen Company Details
Table 126. Amgen Business Overview
Table 127. Amgen Small Cell Lung Cancer Therapeutics Product
Table 128. Amgen Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Amgen Recent Development
Table 130. Ono Pharmaceutical Company Details
Table 131. Ono Pharmaceutical Business Overview
Table 132. Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Product
Table 133. Ono Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Ono Pharmaceutical Recent Development
Table 135. Shanghai Jinhe Bio-Technology Company Details
Table 136. Shanghai Jinhe Bio-Technology Business Overview
Table 137. Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Product
Table 138. Shanghai Jinhe Bio-Technology Revenue in Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Shanghai Jinhe Bio-Technology Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Cell Lung Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Biologics Features
Figure 3. Small molecules Features
Figure 4. Global Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Small Cell Lung Cancer Therapeutics Report Years Considered
Figure 9. Global Small Cell Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Small Cell Lung Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Small Cell Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Small Cell Lung Cancer Therapeutics Market Share by Players in 2020
Figure 14. Global Top Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Small Cell Lung Cancer Therapeutics Revenue in 2020
Figure 16. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Share by Region (2016-2027)
Figure 38. China Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 60. Menarini Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 61. Ziopharm Oncology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 66. Teva Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 69. Sun Pharmaceuticals Industries Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 70. Amgen Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 71. Ono Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 72. Shanghai Jinhe Bio-Technology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の扁平上皮非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Squamous Non-Small Cell Lung Cancer Therapeutics Market The global Squamous Non-Small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…